期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

亚临床甲状腺疾病与心血管疾病 被引量：8

下载PDF
导出
摘要 亚临床甲状腺疾病是临床上常见的内分泌疾病,其与心血管疾病的关系已成为研究热点。本文综述了亚临床甲状腺疾病的流行病学、病因和发病机制、鉴别诊断、与心血管疾病的关系及防治等方面的进展。
作者 李文鹏 李悦
机构地区 哈尔滨医科大学附属第一医院心内五科
出处 《中国循环杂志》 CSCD 北大核心 2013年第5期393-395,共3页 Chinese Circulation Journal
关键词 亚临床甲状腺疾病 亚临床甲状腺功能亢进 亚临床甲状腺功能减退 心血管疾病
分类号 R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献27

  • 1Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA, 2006, 295: 1033-1041.
  • 2Laurberg P, Cerqueira C, Ovesen L, et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab, 2010, 24: 13-27.
  • 3Cooper OS, Biondi B. Subclinical thyroid disorders Authors' reply. Lancet, 2012, 380: 336-337.
  • 4Belin RM, Astor BC, Powe NR, et al. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol Metab, 2004,89:6077-6086.
  • 5Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med, 2012,172:799-809.
  • 6Auer JA, Scheibner P, Mische T, et al. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J, 2001, 142: 838-842.
  • 7Sgarbi JA, Villaca F, Garbeline B, et al. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. Clin Endocrinol Metab, 2003, 88: 1672-1677.
  • 8Petretta M, Bonaduce 0, Spinelli L, et a l , Cardiovascular haemodynamic and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol, 2001, 145: 691-696.
  • 9Dorr M, Robinson OM, Wallaschofski H, et al. Low serum thyrotropin is associated with high plasma fibrinogen. Clin Endocrinol Metab, 2006,91:530-534.
  • 10Pakula 0, Marek B, Kajdaniuk 0, et al. Plasma levels of NT-pro?brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism. Endokrynol Pol, 2011, 62: 523- 528.

二级参考文献24

  • 1Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation ,2002,105 : 1135-1143.
  • 2Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J,2000,21:1584-1590.
  • 3Schnabel R, Rupprecht HJ, Lackner KJ, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J,2005,26:241-249.
  • 4Tommasi S, Carluccio E, Bentivoglio M, et al. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol, 1999,83 : 1595-1599.
  • 5Mega JL, Morrow DA, De Lemos JA, et al. B-type natfiuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction : an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol, 2004,44:335-339.
  • 6Akkus MN, Polar G, Yurtdas M, et al. Admission levels of C-reac- tive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission. Int Heart J,2009,50:33-45.
  • 7Berton G, Cordiano R, Palmieri R, et al. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J, 2003,145 : 1094-1101.
  • 8Scifica BM, Morrow DA, Cannon CP, et al. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clinical Chemistry,2007,53 : 1800-1807.
  • 9Katayama T, Iwasaki Y, Yamamoto T, et al. "Smoker' s paradox" in patients with acute myocardial infarction receiving primary coronary intervention . Cardio1,2006,48 : 193-200.
  • 10Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coil Cardio1,2006 ,47 :962-968.

共引文献88

同被引文献61

  • 1邢惠莉,秦利,方文军,金杰,冯绮文,胡静芳,陈雪茹,陈寒蓓,董艳,殷峻,苏青.上海宝山地区亚临床甲状腺功能减退症的流行病学研究[J].上海医学,2006,29(4):225-226. 被引量：10
  • 2Krysiak R,Szkrobka W,Okopien B.The effect of metfor-min on the hypothalamic-pituitary-thyroid axis in pat-ients with type 2 diabetes and subclinical hyperthy-roidism[J].Exp Clin Endocrinol Diabetes,2015,123(4):205-208.
  • 3Mark PD,Andreassen M,Petersen CL,et al.Treatment of subclinical hyperthyroidism:effect on left ventricular mass and function of the heart using magnetic resonance imaging technique[J].Endocr Connect,2015,4(1):37-42.
  • 4Ling Y, Jiang J, Gui M, et al. Thyroid function, prevalent coronary heart disease, and severity of conmmy atherosclerosis in patients un- dergoing coronary angiography [ J ]. Int J Endocrinol, 2015 ( 2 ) : 708272. DOI : 10.1155/2015/708272.
  • 5Isgtiven P, Gtindtiz Y, Kilic M. Effects of thyroid autoimmunity on early atherosclerosis in euthyroid girls with hashimoto "s thyroiditis [ J ]. J Clin Res Pediatr Endocrino1,2016,8 ( 2 ) : 150-156. DOI : 10. 4274/jcrpe. 2145.
  • 6Gao CX, Yang B, Guo Q, et al. High thyroid-stimulating hormone lev- el is associated with the risk of developing atherosclerosis in subclini- cal hypothyroidism [ J ]. Hormone and Metabolic Research, 2015,47 (3) :220-224. DOI : 10. 1055/s~0034-1394370.
  • 7Deyneli O, Akpnar IN, Merililer OS, et al. Effects of levothyroxine treatment on insulin sensitivity, endothelial function and risk faetors of atherosclerosis in hypothyroid women [ J ]. Ann Endocrinol ( Par- is) ,2014,75(4) :220-226. DOI:10. 1016/j. ando. 2014.06.002.
  • 8Mork LM, Rehnmark S, Davoodpour P, et al. The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cho- lesterol in the circulation in ApoE deficient mice[ J ]. PLoS One,2013,8 (12) : e78534. DOI : 10. 1371/journal. pone. 0078534.
  • 9Mcleod DS. Autoimmune thyroiid disease : a novel risk factor for ath- erosclerosis .9 [ J ]. Endocrine, 2013,44 ( 1 ) : 8-10. DOI : 10. 1007/ s12020-013-9952-8.
  • 10Yildiz M. Thyroid hormones May contribute to vascular risk factors and atherosclerosis [ J ]. Epilepsia, 2012,53 ( 4 ) : 763. DOI : 10. 1111/j. 1528-1167. 2012. 03434. x.

引证文献8

二级引证文献44

中国循环杂志
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部